Already a Bloomberg.com user?
Sign in with the same account.
Don't have an account?
Help! I can't access my account.
Dec. 3 (Bloomberg) -- AxoGen CEO Karen Zaderej discusses regenerative medicine and the impact of the new tax on medical devices. She speaks with Pimm Fox on Bloomberg Television's "Taking Stock." (Source: Bloomberg)
On Air Now
Taking Stock with Pimm Fox
Max 250 characters
©2014 Bloomberg L.P. All Rights Reserved. Made in NYC